US Bancorp’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$150	Buy	10 +1	+11%	+$15	﹤0.01%	4086
2025 Q1	$145	Buy	+9	New	+$145	﹤0.01%	4100
2024 Q4	–	Sell	-9	Closed	-$265	–	4242
2024 Q3	$265	Buy	+9	New	+$265	﹤0.01%	3968